Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Karin Jirström"'
Autor:
Somayeh Khazaei, Ana Bosch, Helena Jernström, Christopher Godina, Edward Visse, Karolin Isaksson, Helga Tryggvadottir, Karin Jirström, Björn Nodin, Signe Borgquist
Publikováno v:
Godina, C, Khazaei, S, Tryggvadottir, H, Visse, E, Nodin, B, Jirström, K, Borgquist, S, Bosch, A, Isaksson, K & Jernström, H 2021, ' Prognostic impact of tumor-specific insulin-like growth factor binding protein 7 (IGFBP7) levels in breast cancer : A prospective cohort study ', Carcinogenesis, vol. 42, no. 11, pp. 1314-1325 . https://doi.org/10.1093/carcin/bgab090
Carcinogenesis
Carcinogenesis
The prognostic impact of insulin-like growth factor binding protein 7 (IGFBP7) in breast cancer is unclear. Host factors, including lifestyle, anthropometry and metabolic profile, might influence tumor-specific IGFBP7. This study aimed to investigate
Autor:
Jakob Eberhard, Christina Siesing, Hans Brunnström, Karin Jirström, Björn Nodin, Halla Vidarsdottir, Per Jönsson
Publikováno v:
Journal of Surgical Oncology. 123:1144-1156
Background The lungs are the second most common site of metastases in colorectal cancer (CRC). The aim of this study was to investigate prognostic factors, including RNA‐binding motif protein 3 (RBM3) expression, in patients with CRC treated with p
Autor:
Artur Mezheyeuski, Max Backman, Johanna Mattsson, Alfonso Martín-Bernabé, Chatarina Larsson, Ina Hrynchyk, Klara Hammarström, Simon Ström, Joakim Ekström, Siarhei Mauchanski, Salome Khelashvili, Amanda Lindberg, Margrét Agnarsdóttir, Per-Henrik Edqvist, Jutta Huvila, Ulrika Segersten, Per-Uno Malmström, Johan Botling, Björn Nodin, Charlotta Hedner, David Borg, Jenny Brändstedt, Hanna Sartor, Karin Leandersson, Bengt Glimelius, Anna Portyanko, Fredrik Ponten, Karin Jirström, Patrick Micke, Tobias Sjöblom
Publikováno v:
eBioMedicine. 88:104452
Background: Cancer immunity is based on the interaction of a multitude of cells in the spatial context of the tumour tissue. Clinically relevant immune signatures are therefore anticipated to fundamentally improve the accuracy in predicting disease p
Autor:
Emma Sandén, Helena Jernström, Signe Borgquist, Karolin Isaksson, Helga Tryggvadottir, Karin Jirström, Somayeh Khazaei
Publikováno v:
Sandén, E, Khazaei, S, Tryggvadottir, H, Borgquist, S, Isaksson, K, Jirström, K & Jernström, H 2020, ' Re-evaluation of HER2 status in 606 breast cancers—gene protein assay on tissue microarrays versus routine pathological assessment ', Virchows Archiv, vol. 477, no. 2, pp. 317-320 . https://doi.org/10.1007/s00428-020-02768-x
Virchows Archiv
Virchows Archiv
Human epidermal growth factor receptor 2 (HER2) status in breast cancer is routinely determined through immunohistochemistry (IHC) and/or in situ hybridisation (ISH) performed on whole tissue sections (WS). The purpose was to evaluate whether a gene
Autor:
Karin Jirström, Maria Planck, Johanna Sofia Margareta Mattsson, Björn Nodin, Johan Botling, Johan Staaf, Hans Brunnström, Linnea Söderlund, Patrick Micke, Halla Vidarsdottir, Lena Tran
Publikováno v:
Archives of Pathology & Laboratory Medicine. 144:1075-1085
Context.— The diagnostic distinction of pulmonary neuroendocrine (NE) tumors from non–small cell lung carcinomas (NSCLCs) is clinically relevant for prognostication and treatment. Diagnosis is based on morphology and immunohistochemical staining.
Autor:
Bengt Glimelius, Sebastian Lundgren, Jenny Brändstedt, Hans Brunnström, Aine O´Reilly, Johan Botling, Agnieszka Krzyzanowska, Sara Corvigno, Karin Jirström, Hanna Dahlstrand, J Huvila, Max Backman, Fredrik Pontén, Alfonso Martín-Bernabé, Siarhei Mauchanski, Ina Hrynchyk, Hanna Sartor, Björn Nodin, David Borg, Carina Strell, Patrick Micke, Gemma Garcia-Vicién, Salome Khelashvili, Ulrika Segersten, Johanna Sofia Margareta Mattsson, Cecilia Lindskog, Artur Mezheyeuski, Jacob Elebro, Per Henrik Edqvist, Anders Bjartell, Fredrik Wärnberg, Margareta Heby, Malin Sund, David G. Molleví, Per-Uno Malmström, Martin Johansson, Charlotta Hedner
Publikováno v:
EBioMedicine, Vol 65, Iss, Pp 103269-(2021)
Dipòsit Digital de la UB
Universidad de Barcelona
EBioMedicine
Dipòsit Digital de la UB
Universidad de Barcelona
EBioMedicine
Background The development of a reactive tumour stroma is a hallmark of tumour progression and pronounced tumour stroma is generally considered to be associated with clinical aggressiveness. The variability between tumour types regarding stroma fract
Autor:
Maria Planck, Karin Jirström, Johan Botling, Björn Nodin, Hans Brunnström, Patrick Micke, Johanna Sofia Margareta Mattsson, Per Jönsson, Halla Vidarsdottir, Lena Tran
Publikováno v:
American Journal of Clinical Pathology. 150:533-544
Objectives: Immunohistochemical staining against thyroid transcription factor 1 (TTF-1) is often used to distinguish lung adenocarcinoma from squamous cell carcinoma and pulmonary metastasis.Methods: TTF-1 expression was examined using the antibody c
Autor:
Margareta Heby, Björn Nodin, Jacob Elebro, Jakob Eberhard, Karin Jirström, Sebastian Lundgren
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-12 (2018)
Journal of Translational Medicine
Journal of Translational Medicine
Background Periampullary adenocarcinomas, including pancreatic cancer, are a heterogeneous group of tumors with poor prognosis, where classification into intestinal type (I-type) or pancreatobiliary type (PB-type) is a relevant prognostic factor. The
Autor:
Karin Leandersson, Catharina Hagerling, Eva Desmond, Carl Fredrik Warfvinge, Karin Jirström, Roni Allaoui
Publikováno v:
Cancer Biomarkers
BACKGROUND: Tumor-infiltrating lymphocytes (TILs) have a strong prognostic value in various forms of cancers. These data often refer to use of the pan-T cell marker CD3, or the cytotoxic T lymphocyte marker CD8α. However, T cells are a heterogeneous
Autor:
Olivier Govaere, Teresa Laguna, Mona Foth, F. Javier Carmona, Karin Jirström, Balázs Bálint, Kieran Sheahan, Manel Esteller, William M. Gallagher, Joost van den Oord, Girish Mallya-Udupi, Anna Martínez-Cardús, Roy Cloots, Claudia Aura, Jasper Wouters, Jesuchristopher Joseph, Ian G. Murphy, Peter Dynoodt, Karin van den Hurk, Björn Nodin, Miguel Vizoso, Enda W. McDermott
Publikováno v:
BMC Medicine, Vol 15, Iss 1, Pp 1-16 (2017)
BMC Medicine, 15:101. BioMed Central Ltd
BMC Medicine
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
BMC Medicine, 15:101. BioMed Central Ltd
BMC Medicine
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
Background Cutaneous melanoma is the deadliest skin cancer, with an increasing incidence and mortality rate. Currently, staging of patients with primary melanoma is performed using histological biomarkers such as tumor thickness and ulceration. As di